Supplementary Figure S4 from Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial
Key Points
Key points are not available for this paper at this time.
Abstract
Supplementary Figure S4. Time to PSA progression (TTP).
Supplementary Figure S4 from Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial | Synapse